Quincy, MA, United States of America

Thiwanka Samarakoon

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 204(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Thiwanka Samarakoon: Innovator in Anti-Cancer Compounds

Introduction

Thiwanka Samarakoon is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit anti-cancer and anti-proliferative activities. With a total of four patents to his name, Samarakoon is recognized for his innovative approach to addressing serious health issues.

Latest Patents

Samarakoon's latest patents include the development of N-acyl-N'-(pyridin-2-yl) ureas and analogs. These compounds are designed to treat cancer, autoimmune diseases, and metabolic bone disorders by inhibiting c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. The utility of these compounds extends to the treatment of other mammalian diseases mediated by these kinases, showcasing their potential impact on various health conditions.

Career Highlights

Thiwanka Samarakoon is currently employed at Deciphera Pharmaceuticals, LLC, where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in the creation of innovative treatments that can improve patient outcomes.

Collaborations

Samarakoon collaborates with esteemed colleagues, including Daniel L Flynn and Timothy Malcolm Caldwell. These partnerships enhance the research environment and contribute to the successful development of new therapeutic compounds.

Conclusion

Thiwanka Samarakoon is a dedicated inventor whose work in anti-cancer compounds is making a significant difference in the medical field. His innovative contributions and collaborations are paving the way for new treatments that could benefit many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…